Alaunos Therapeutics Inc. (TCRT)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity Share change % change to portfolio
Q3  2021
Bill Miller - Miller Value Partners Sell 100.00% 687,847 0.71
Q2  2021
Bill Miller - Miller Value Partners Reduce 12.82% 101,132 0.10
Q1  2021
Bill Miller - Miller Value Partners Reduce 5.07% 42,106 0.06
Q4  2020
Bill Miller - Miller Value Partners Add 0.65% 5,377 0.01
Q3  2020
Bill Miller - Miller Value Partners Reduce 1.86% 15,610 0.02
Q2  2020
Bill Miller - Miller Value Partners Reduce 1.85% 15,821 0.03
Q1  2020
Bill Miller - Miller Value Partners Add 0.96% 8,186 0.02
Q4  2019
Bill Miller - Miller Value Partners Reduce 1.92% 16,595 0.04
Q3  2019
Bill Miller - Miller Value Partners Add 40.52% 249,599 0.65
Q1  2019
Bill Miller - Miller Value Partners Reduce 0.28% 1,704 0.00
Q4  2018
Bill Miller - Miller Value Partners Add 92.31% 296,476 0.36
Q3  2018
Bill Miller - Miller Value Partners Reduce 2.02% 6,609 0.01
Q2  2018
Bill Miller - Miller Value Partners Reduce 2.41% 8,085 0.01
Q1  2018
Bill Miller - Miller Value Partners Reduce 0.91% 3,087 0.01
Q4  2017
Bill Miller - Miller Value Partners Add 4.65% 15,059 0.04
Q3  2017
Bill Miller - Miller Value Partners Reduce 1.38% 4,540 0.02
Q2  2017
Bill Miller - Miller Value Partners Add 0.02% 75 0.00
Q1  2017
Bill Miller - Miller Value Partners Add 0.50% 1,640 0.01
Q4  2016
Bill Miller - Miller Value Partners Reduce 2.10% 7,014 0.03
Q2  2016
Bill Miller - Miller Value Partners Reduce 8.46% 30,840 0.16
Q3  2015
Daniel Loeb - Third Point Sell 100.00% 130,000 0.23
Q2  2015
Daniel Loeb - Third Point Buy 130,000 0.23

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.